Literature Search Strategy

OVERVIEW

Interface:

Ovid

Databases:

Embase 1974 to present
MEDLINE Daily and MEDLINE 1946 to present
MEDLINE In-Process & Other Non-Indexed Citations
Note: Subject headings have been customized for each database. Duplicates between databases were removed in Ovid.

Date of Search:

May 21, 2015

Alerts:

Bi-weekly search updates until project completion

Study Types:

No search filters were applied

Limits:

No date or language limits were used
Conference abstracts were excluded

SYNTAX GUIDE

At the end of a phrase, searches the phrase as a subject heading

.sh

At the end of a phrase, searches the phrase as a subject heading

MeSH

Medical Subject Heading

Floating subheading

exp

Explode a subject heading

Before a word, indicates that the marked subject heading is a primary topic; or, after a word, a truncation symbol (wildcard) to retrieve plurals or varying endings

Truncation symbol for one character

Truncation symbol for one or no characters only

adj

Requires words are adjacent to each other (in any order)

adj#

Adjacency within # number of words (in any order)

.ti

Title

.ab

Abstract

.ot

Original title

.hw

Heading word; usually includes subject headings and controlled vocabulary

.pt

Publication type

.po

Population group [PsycInfo only]

.rn

CAS registry number

.nm

Name of substance word

pmez

Ovid database code; MEDLINE In-Process & Other Non-Indexed Citations, MEDLINE Daily and Ovid MEDLINE 1946 to Present

oemezd

Ovid database code; Embase 1974 to present, updated daily

MULTI-DATABASE STRATEGY

(Jardiance* or empagliflozin* or Bl 10773 or BI-10773 or BI10773 or UNII-HDC1R2M35U or UNIIHDClR2M35U).ti,ab,m,nm,sh,hw,ot.
(864070-44-0 or “864070440” or “864070 44 0” or “86407044 0” or 864070 440).rn,nm.
1 or 2
3 use pmez
*empagliflozin/
(Jardiance* or empagliflozin* or Bl 10773 or BI-10773 or BI10773 or UNII-HDC1R2M35U or UNIIHDClR2M35U).ti,ab.
conference abstract.pt.
(5 or 6) not 7
8 use oemezd
4 or 9
remove duplicates from 10
exp animals/
exp animal experimentation/ or exp animal experiment/
exp models animal/
nonhuman/
or/12-15
exp humans/
exp human experimentation/
exp human experiment/
17 or 18 or 19
16 not 20
11 not 21

OTHER DATABASES

PubMed

Same MeSH, keywords, limits, and study types used as per MEDLINE search, with appropriate syntax used.

Trial registries (Clinicaltrials.gov and others)

Same keywords, limits used as per MEDLINE search.

Grey Literature

Dates for Search:	May 2015
Keywords:	Jardiance, empagliflozin, BI10773, diabetes, SGLT-2 inhibitors
Limits:	No date or language limits used

Relevant websites from the following sections of the CADTH grey literature checklist, “Grey matters: a practical tool for evidence-based searching” (http://www.cadth.ca/en/resources/finding-evidence-is/grey-matters), were searched:

Health Technology Assessment Agencies

Health Economics

Clinical Practice Guidelines

Drug and Device Regulatory Approvals

Advisories and Warnings

Drug Class Reviews

Databases (free)

Internet Search.

The copyright and other intellectual property rights in this document are owned by CADTH and its licensors. These rights are protected by the Canadian Copyright Act and other national and international laws and agreements. Users are permitted to make copies of this document for non-commercial purposes only, provided it is not modified when reproduced and appropriate credit is given to CADTH and its licensors.

Except where otherwise noted, this work is distributed under the terms of a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International licence (CC BY-NC-ND), a copy of which is available at http://creativecommons.org/licenses/by-nc-nd/4.0/

Bookshelf ID: NBK534173

Contents

< Prev Next >

Bookshelf

Clinical Review Report: Empagliflozin (Jardiance) [Internet].

APPENDIX 2Literature Search Strategy

Grey Literature

Views

Other titles in this collection

Recent Activity